| |
| |
|
| Insider
Information: |
Bergstrom Donald A |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
527,427 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,597,052 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
527,427 |
|
|
| Total
Value |
$3,597,052 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
18
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
16
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -556.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mersana Therapeutics, Inc. |
MRSN |
|
|
0 |
|
0 |
Premium* |
|
|
Relay Therapeutics, Inc. |
RLAY |
|
2024-04-29 |
527,427 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RLAY |
Relay Therapeutics, Inc. |
See RemarksOfficer |
• – – |
2020-07-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
98,566 |
|
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-03-29 |
4 |
S |
$29.87 |
$18,579 |
D/D |
(622) |
94,304 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
See Remarks |
• – – |
2021-09-27 |
4 |
S |
$36.87 |
$23,818 |
D/D |
(646) |
75,619 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2023-06-27 |
4 |
S |
$12.12 |
$7,842 |
D/D |
(647) |
240,587 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2023-09-27 |
4 |
S |
$8.38 |
$5,430 |
D/D |
(648) |
238,484 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
See Remarks |
• – – |
2021-12-27 |
4 |
S |
$33.10 |
$21,482 |
D/D |
(649) |
44,970 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2023-03-27 |
4 |
S |
$15.36 |
$11,720 |
D/D |
(763) |
244,084 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2024-03-27 |
4 |
S |
$7.70 |
$5,891 |
D/D |
(765) |
530,113 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
See Remarks |
• – – |
2021-06-28 |
4 |
S |
$35.81 |
$34,951 |
D/D |
(976) |
76,265 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-09-27 |
4 |
S |
$22.73 |
$22,184 |
D/D |
(976) |
88,683 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2023-12-27 |
4 |
S |
$11.51 |
$11,245 |
D/D |
(977) |
234,056 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-12-27 |
4 |
S |
$14.49 |
$14,200 |
D/D |
(980) |
85,886 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-06-27 |
4 |
AS |
$20.31 |
$20,290 |
D/D |
(999) |
91,494 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2023-06-30 |
4 |
A |
$10.68 |
$13,115 |
D/D |
1,228 |
241,815 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2023-04-28 |
4 |
S |
$11.16 |
$15,434 |
D/D |
(1,383) |
242,701 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2023-01-30 |
4 |
S |
$21.56 |
$30,809 |
D/D |
(1,429) |
244,847 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-04-28 |
4 |
AS |
$25.57 |
$46,307 |
D/D |
(1,811) |
92,493 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-10-28 |
4 |
AS |
$21.54 |
$39,138 |
D/D |
(1,817) |
86,866 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-07-28 |
4 |
S |
$21.27 |
$39,030 |
D/D |
(1,835) |
89,659 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2023-07-28 |
4 |
S |
$11.80 |
$31,659 |
D/D |
(2,683) |
237,904 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2024-04-29 |
4 |
S |
$6.38 |
$17,137 |
D/D |
(2,686) |
527,427 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2023-04-28 |
4/A |
S |
$11.16 |
$31,806 |
D/D |
(2,850) |
241,234 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2024-01-29 |
4 |
S |
$9.64 |
$30,636 |
D/D |
(3,178) |
530,878 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2023-10-30 |
4 |
S |
$6.03 |
$20,810 |
D/D |
(3,451) |
235,033 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President, R&D |
• – – |
2022-09-02 |
4 |
AS |
$25.46 |
$124,754 |
D/D |
(4,900) |
89,659 |
0 |
% |
|
62 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
